Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
$536M |
| 2 |
Apple
AAPL
|
$362M |
| 3 |
Micron Technology
MU
|
$270M |
| 4 |
Eli Lilly
LLY
|
$228M |
| 5 |
Cisco
CSCO
|
$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
$472M |
| 2 |
Tesla
TSLA
|
$463M |
| 3 |
NVIDIA
NVDA
|
$424M |
| 4 |
Coinbase
COIN
|
$236M |
| 5 |
Meta Platforms (Facebook)
META
|
$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Palantir
PLTR
$372B
| $1.43B | 2.15% | 38,419,240 -1,096,069 | -3% | -$40.8M |
|
2
Novo Nordisk
NVO
$251B
| $975M | 1.47% | 8,189,315 -976,059 | -11% | -$116M |
|
3
United Therapeutics
UTHR
$13.8B
| $772M | 1.16% | 2,155,392 -19,300 | -0.9% | -$6.92M |
|
|
4
Apple
AAPL
$3.45T
| $763M | 1.15% | 3,276,203 +1,554,759 | +90% | +$362M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $759M | 1.14% | 1,631,493 +65,105 | +4% | +$30.3M |
|
|
6
Microsoft
MSFT
$3.77T
| $676M | 1.02% | 1,571,271 +1,246,346 | +384% | +$536M |
|
7
VeriSign
VRSN
$25.5B
| $603M | 0.91% | 3,175,990 +148,294 | +5% | +$28.2M |
|
8
Sprouts Farmers Market
SFM
$13.7B
| $490M | 0.74% | 4,440,644 +2,500 | +0.1% | +$276K |
|
9
Airbnb
ABNB
$79.9B
| $459M | 0.69% | 3,616,495 +215,090 | +6% | +$27.3M |
|
|
10
NVIDIA
NVDA
$4.24T
| $428M | 0.64% | 3,528,071 -3,493,719 | -50% | -$424M |
|
11
Exelixis
EXEL
$10.1B
| $399M | 0.6% | 15,359,916 +196,850 | +1% | +$5.11M |
|
12
Franco-Nevada
FNV
$36.3B
| $390M | 0.59% | 3,138,549 +64,600 | +2% | +$8.03M |
|
13
Cboe Global Markets
CBOE
$24.7B
| $385M | 0.58% | 1,879,724 +5,000 | +0.3% | +$1.02M |
|
14
Fortinet
FTNT
$60.4B
| $383M | 0.58% | 4,943,162 -83,232 | -2% | -$6.45M |
|
|
15
Meta Platforms (Facebook)
META
$1.86T
| $371M | 0.56% | 647,424 -398,709 | -38% | -$228M |
|
16
Gilead Sciences
GILD
$140B
| $351M | 0.53% | 4,188,524 -869,074 | -17% | -$72.9M |
|
17
Allison Transmission
ALSN
$7.3B
| $329M | 0.49% | 3,423,419 -99,100 | -3% | -$9.52M |
|
18
monday.com
MNDY
$9.95B
| $316M | 0.48% | 1,138,290 +15,600 | +1% | +$4.33M |
|
19
DoorDash
DASH
$105B
| $312M | 0.47% | 2,186,688 -601,155 | -22% | -$85.8M |
|
20
CME Group
CME
$96B
| $310M | 0.47% | 1,403,089 +784,500 | +127% | +$173M |
|
21
Corcept Therapeutics
CORT
$7.35B
| $301M | 0.45% | 6,509,002 -403,569 | -6% | -$18.7M |
|
22
Netflix
NFLX
$513B
| $298M | 0.45% | 420,209 +148,509 | +55% | +$105M |
|
23
Incyte
INCY
$16.5B
| $297M | 0.45% | 4,499,540 -718,797 | -14% | -$47.5M |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $297M | 0.45% | 2,574,546 +106,400 | +4% | +$12.3M |
|
25
Wingstop
WING
$9.16B
| $291M | 0.44% | 699,146 +96,156 | +16% | +$40M |
|